LXR/RXR activation‡ | IL-12 signaling** | HGF signaling† |
PXR/RXR activation‡ | Role of IL-17F in inflammatory airway diseases** | GPCR signaling |
Neuroprotective role of THOP1 in Alzheimer's disease | Role of pattern recognition receptors in bacteria and viruses** | LPS-stimulated MAPK signaling** |
Hepatic cholestasis | GPCR signaling | Prostanoid biosynthesis |
VDR/RXR activation‡ | FLT3 signaling in hematopoietic progenitor cells | IL-12 signaling and production in macrophages** |
LPS/IL-1 mediated inhibition of RXR function | Fcγ receptor-mediated phagocytosis in macrophages** | CD28 signaling in T helper cells** |
TR/RXR activation‡ | VDR/RXR activation‡ | 14–3-3-mediated signaling |
Oleate biosynthesis†† | Reelin signaling in neurons | Erythropoietin signaling |
P38 MAPK signaling | cAMP-mediated signaling | Macropinocytosis signaling |
Complement system | Production of reactive oxygen species in macrophages | Renal cell carcinoma signaling |
Coagulation system | Molecular mechanisms of cancer | Protein kinase A signaling |
Chondroitin sulfate degradation* | LXR/RXR activation‡ | Glioma signaling |
Visual cycle | T helper cell differentiation** | P2Y purigenic receptor signaling pathway |
Dermatan sulfate degradation* | Factors promoting cardiogenesis | IL-3 signaling** |
Parkinson's signaling | p38 MAPK signaling | Prolactin signaling |
Epoxysqualene synthesis†† | MSP-RON signaling pathway | PI3K signaling in B lymphocytes** |
Palmitate biosynthesis†† | Hepatic fibrosis/hepatic stellate cell activation | Huntington's disease signaling |
Fatty acid biosynthesis initiation†† | LPS-stimulated MAPK signaling** | Breast cancer regulation by stathmin1 |
Threonine degradation | EGF signaling† | Role of IL-17A in arthritis** |
Granulocyte adhesion and diapedesis | NF-κB signaling** | VDR/RXR activation‡ |
Glutathione redox reactions | Dendritic cell maturation** | Glucocorticoid receptor signaling** |
PPARα/RXRα activation‡ | TREM1 signaling** | Regulation of IL-2 expression in activated and anergic T lymphocytes** |
cAMP-mediated signaling | FGF signaling† | Inhibition of angiogenesis by TSP1 |
Type I diabetes mellitus signaling | Neurotrophin/TRK signaling† | Pancreatic adenocarcinoma signaling |
Oct4 in ES pluripotency | PI3K signaling in B lymphocytes** | NF-κB signaling** |